Farmanews.com

Especialidades y enfermedades  
Farmacéuticas

Farmacéuticas. 15 de enero de 2018

Japanese pharma: No longer 'lost in translation'

Amsterdam, 15th January 2018: A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April, 2018) – has identified that demographic pressures on healthcare costs are driving a political agenda that will benefit players with lower costs solutions. Generics are an obvious route, but Japan’s status as a highly-developed economy with a pharma industry that leads in innovation opens other possibilities, particularly in the longer term for the biosimilars segment. In fact, an overwhelming 59% of domestic respondents believe biosimilars will be the fastest growing sector.
Acceder
Farmacéuticas. 11 de diciembre de 2017

Envigo implements first-in-class surgical model tracking system

Groundbreaking software provides real-time tracking, accuracy and data access
Acceder
Farmacéuticas. 06 de diciembre de 2017

ADC Bio signs construction agreement with sector specialists WHP

Construction on state of the art bioconjugation facility for clinical and commercial ADC drug manufacturing to begin immediately
Acceder
Farmacéuticas. 05 de diciembre de 2017

Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells

5 December 2017: Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisation dedicated to saving the lives of people with blood cancers, to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.
Acceder
Farmacéuticas. 01 de diciembre de 2017

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

Since the MAH pilot launch, the company has undertaken eight development programs.
Acceder
Farmacéuticas. 21 de noviembre de 2017

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology
Acceder
Farmacéuticas. 15 de noviembre de 2017

Pharma set for prosperous 2018 as 44,500* attend CPhI Worldwide

Germany tops quality-ranking categories in the inaugural CPhI Global Pharma Index
Acceder
Farmacéuticas. 14 de noviembre de 2017

Poor aggregation will see ADC targets fail or face long delays

Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs
Acceder

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   


Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2018, Farmavet, S.L. Todos los derechos reservados.